Portal Hypertension 2005
DOI: 10.1007/978-1-59259-885-4_4
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Mechanisms of Systemic Vasodilation and Hyperdynamic Circulatory State of Cirrhosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2006
2006
2011
2011

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 105 publications
0
3
0
Order By: Relevance
“…In portal hypertension, despite NOS and COX inhibition, arterial vasodilation, and vascular hyporeactivity are not totally suppressed, suggesting the presence of NOS/COX independent vasodilators (Moreau and Lebrec,1995). Increased plasma levels of natriuretic peptides, glucagon, adrenomedulin, calcitonin gene‐related peptide, substance P, and vasoactive intestinal peptide have been described in cirrhosis (Moreau and Lebrec,1995,2005). Probably, other vasodilators will be discovered in the future…”
Section: Mechanism Of Splanchnic Hyperdynamic Circulationmentioning
confidence: 99%
See 1 more Smart Citation
“…In portal hypertension, despite NOS and COX inhibition, arterial vasodilation, and vascular hyporeactivity are not totally suppressed, suggesting the presence of NOS/COX independent vasodilators (Moreau and Lebrec,1995). Increased plasma levels of natriuretic peptides, glucagon, adrenomedulin, calcitonin gene‐related peptide, substance P, and vasoactive intestinal peptide have been described in cirrhosis (Moreau and Lebrec,1995,2005). Probably, other vasodilators will be discovered in the future…”
Section: Mechanism Of Splanchnic Hyperdynamic Circulationmentioning
confidence: 99%
“…In normal circumstances NO stimulates the production of cGMP which activates cGMP dependent serine‐threonine protein kinase called “PKG” (Lincoln and Cornwell,1993). PKG inhibits the GPCR signaling pathway used by vasoconstrictors at different levels: (1) PKG increases GTPase activity terminating vasoconstrictor signalling (Tang et al,2003); (2) PKG may phosphorylate GPCR and thus uncouple the receptor and G‐proteins (Lincoln and Cornwell,1993; Moreau and Lebrec,2005).…”
Section: Mechanism Of Splanchnic Hyperdynamic Circulationmentioning
confidence: 99%
“…During the course of the disease, rising pressure differences lead to an increased risk of hepatic encephalopathy, hepatorenal syndrome, and the dreaded complication of acute variceal rupture. Unfortunately, once collaterals have developed, increased levels of circulating endogenous vasodilators that result from the underlying liver disease, can lead to further increases in portal venous flow, exacerbating the risk of variceal rupture and other complications (3).…”
mentioning
confidence: 99%